Fig. 3From: Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with gliomaBox plot assessing TPM4 expression in patients with glioma according to different clinical characteristics. WHO grade (A), IDH status (B), 1p/19q codeletion (C), primary therapy outcome (D), and histological type (E)Back to article page